Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01357408 · ClinicalTrials.gov registry record
Heart Failure and Risk of Re-Admissions Determined by Abnormal REVEAL Parameters
A clinical trial, sponsored by Thomas Jefferson University.
- Terminated
- Registry status
- 40
- Enrollment target
NCT01357408 is a clinical trial that was terminated before completion, run by Thomas Jefferson University. The registered enrollment target is 40 participants.
The verdict
NCT01357408 was terminated before completion, sponsored by Thomas Jefferson University.
- TERMINATED
- Registry status
- 40 participants
- Enrollment target
Study Summary
The purpose of the Heart Failure and Risk of re-Admissions Determined by Abnormal REVEAL Parameters (HF RADAR) study is to evaluate the ability of cardiac rhythm (Cardiac Compass) data to predict future cardiac events in heart failure (HF) patients recently discharged after a hospitalization for heart failure who have or plan to have a implanted loop recorder (ILR), specifically, the Reveal XT device. The study will enroll 40 HF patients (with LV function ≥ 40%) admitted to an acute care facility (observation status or hospital stay) for heart failure who either have a Reveal XT device in place or plan to have the ILR device inserted for clinical indication within 14 days of discharge from the hospitalization. HF patients will be followed for 6 months. Device date will be captured during normal clinic visits and at 6 months.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2011-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01357408
The ClinicalTrials.gov registry entry for NCT01357408 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01357408 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01357408 about?
NCT01357408 is a clinical study titled "Heart Failure and Risk of Re-Admissions Determined by Abnormal REVEAL Parameters". The purpose of the Heart Failure and Risk of re-Admissions Determined by Abnormal REVEAL Parameters (HF RADAR) study is to evaluate the ability of cardiac rhythm (Cardiac Compass) data to predict future cardiac events in heart failure (HF) patients recently discharged after a hospitalization for hea...
What is the current status of trial NCT01357408?
This trial is currently terminated. The enrollment target is 40 participants. The study started on 2011-05.
Who is sponsoring clinical trial NCT01357408?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.